Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence
dc.contributor.author | Sleath, Betsy | |
dc.contributor.author | Carpenter, Delesha M | |
dc.contributor.author | Blalock, Susan J | |
dc.contributor.author | Davis, Scott A | |
dc.contributor.author | Hickson, Ryan P | |
dc.contributor.author | Lee, Charles | |
dc.contributor.author | Ferreri, Stefanie P | |
dc.contributor.author | Scott, Jennifer E | |
dc.contributor.author | Rodebaugh, Lisa B | |
dc.contributor.author | Cummings, Doyle M. | |
dc.date.accessioned | 2020-05-05T16:26:19Z | |
dc.date.available | 2020-05-05T16:26:19Z | |
dc.date.issued | 2016-06-07 | |
dc.description.abstract | Background: Although there are several different general diabetes self-efficacy scales, there is a need to develop a self-efficacy scale that providers can use to assess patient’s self-efficacy regarding medication use. The purpose of this study was to: 1) develop a new diabetes medication self-efficacy scale and 2) examine how diabetes medication self-efficacy is associated with patient-reported problems in using diabetes medications and self-reported adherence. Patients and methods: Adult English-speaking patients with type 2 diabetes were recruited from a family medicine clinic and a pharmacy in Eastern North Carolina, USA. The patients were eligible if they reported being nonadherent to their diabetes medicines on a visual analog scale. Multivariable regression was used to examine the relationship between self-efficacy and the number of reported diabetes medication problems and adherence. Results: The diabetes medication self-efficacy scale had strong reliability (Cronbach’s alpha =0.86). Among a sample (N=51) of mostly African-American female patients, diabetes medication problems were common (6.1±3.1) and a greater number of diabetes medications were associated with lower medication adherence (odds ratio: 0.35; 95% confidence interval: 0.13, 0.89). Higher medication self-efficacy was significantly related to medication adherence (odds ratio: 1.17; 95% confidence interval: 1.05, 1.30) and inversely related to the number of self-reported medication problems (β=-0.13; P=0.006). Conclusion: Higher diabetes medication self-efficacy was associated with fewer patient- reported medication problems and better medication adherence. Assessing medication-specific self-efficacy may help to identify medication-related problems that providers can help the patients address, potentially improving adherence and patient outcomes. Keywords: diabetes, adherence, self-efficacy, literacy | en_US |
dc.identifier.doi | 10.2147/PPA.S101349 | |
dc.identifier.uri | http://hdl.handle.net/10342/8500 | |
dc.title | Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence | en_US |
dc.type | Article | en_US |
ecu.journal.name | Patient Preference and Adherence | en_US |
ecu.journal.pages | 1003–1010 | en_US |
ecu.journal.volume | 10 | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ppa-10-1003.pdf
- Size:
- 317.42 KB
- Format:
- Adobe Portable Document Format
- Description: